San Mateo, United States
Stoparkinson Healthcare Systems Inc, founded in 2019, is a promising player in the Health Care and Medical Devices industries. Known for its slogan, "Developing a wearable device for alleviation of Parkinson disease symptoms", the company has brought innovation to neuromodulation technology through its flagship product, EarStim.
As a venture-funded clinical stage company, Stoparkinson has completed four clinical studies and holds three issued US patents for its non-surgical, user-friendly device aimed at alleviating the symptoms of Parkinson's disease. The EarStim reduces reliance on medications, offering a potential game-changer for patients.
Currently seeking Series A funding of $14M, the company plans to initiate a pivotal FDA study. With its headquarters in the United States, Stoparkinson stands as a strong candidate for investment, presenting an opportunity to support a groundbreaking advancement in healthcare technology.
